1-((4-Methylpiperazin-1-yl)methyl)-1H-benzo[d][1,2,3]triazole

Catalog No.: 
ACGMZK458
CAS No.: 
19212-84-1
Molecular Formula: 
C12H17N5
Molecular Weight: 
231.30
1-((4-Methylpiperazin-1-yl)methyl)-1H-benzo[d][1,2,3]triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$171.00InquiryInquiry
100mg98%$249.00InquiryInquiry
250mg98%$616.00InquiryInquiry
1g98%$2439.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((4-Methylpiperazin-1-yl)methyl)-1H-benzo[d][1,2,3]triazole
IUPAC Name1-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d][1,2,3]triazole
MDL No.MFCD00440079
Molecular FormulaC12H17N5
Molecular Weight231.30
SMILESCN1CCN(CN2N=NC3=CC=CC=C32)CC1
InChI KeyPXJQUDHABLFDIQ-UHFFFAOYSA-N
Synonym1-[(4-Methylpiperazin-1-yl)methyl]-1H-1,2,3-benzotriazole;1H-Benzotriazole, 1-[(4-methyl-1-piperazinyl)methyl]-
CAS No.19212-84-1

Synthetic Route by SureRoute

1. ACGMZK458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFBYI437 route compound structure diagram
    ACFBYI437273-02-9In Stock
  4. Then
  5. ACGMZK458 route product structure diagram
    ACGMZK45819212-84-1
Inquiry

2. ACGMZK458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Plus
  3. ACICQJ406 route compound structure diagram
    ACICQJ40654187-96-1In Stock
  4. Then
  5. ACGMZK458 route product structure diagram
    ACGMZK45819212-84-1
Inquiry

3. ACGMZK458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGMZK458 route product structure diagram
    ACGMZK45819212-84-1
Inquiry

Comments (0)